Alice Ly
Alice Ly is Vice President - Alexandria Venture Investments at Alexandria Real Estate Equities, Inc. and Site head, Alexandria LaunchLabs - Seattle at Alexandria LaunchLabs. She was Program Director of Life Sciences & Healthcare and Associate Director of HILS at Harvard Innovation Labs and Associate Director of Postdoctoral Affairs at Yale University. She is a Board Observer at TwinStrand Biosciences and was a Board Member at Proniras, Magnolia Neurosciences, Rodeo Therapeutics and ApoGen Biotechnologies, Inc.
-
Alexandria Real Estate Equities, Inc. Vice President - Alexandria Venture Investments 2022–present, Principal - Alexandria Venture Investments 2020–2022 · current
-
Alexandria LaunchLabs Site head, Alexandria LaunchLabs - Seattle 2020–present, Site head, Alexandria LaunchLabs - Cambridge 2018–2019 · current
-
TwinStrand Biosciences Board Observer 2019–present · current
-
ApoGen Biotechnologies, Inc. Board Member 2020–2021 · past
-
Magnolia Neurosciences Board Member 2020–2022 · past
-
Proniras Board Member 2020–2022 · past
-
Rodeo Therapeutics Board Member 2020–2021 · past
-
Harvard Innovation Labs Program Director of Life Sciences & Healthcare and Associate Director of HILS 2013–2018 · past
-
Yale University Associate Director of Postdoctoral Affairs 2010–2012, STARS (Science, Technology and Research Scholars) Graduate Coordinator 2009–2010, Yale College Graduate Affiliate 2008–2010, McDougal Fellow 2005–2010 · past
Education
-
Yale University PhD, Developmental Neurobiology
-
Yale University M.S., Molecular, Cellular & Developmental Biology
-
UC Irvine B.S., Biological Sciences